Nama's AI scorecard currently rates Option Care Health Buy (6.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is OPCH's P/E ratio?

Option Care Health trades at a trailing price-to-earnings ratio of 17.6.

When does OPCH report earnings?

Option Care Health's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $0.54.

What is the OPCH price target?

The median analyst price target from 8 analysts is $32.05, with a range of $23.00 – $33.00.

Is OPCH Shariah compliant?

Nama's AAOIFI-style screen reads Option Care Health as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Option Care Health (OPCH)

Healthcare · Medical Care Facilities · NASDAQ

Option Care Health (OPCH) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $4.74B, a trailing price-to-earnings ratio of 17.6 and a free-cash-flow yield of 4.2%. Over the most recent reported fiscal year, revenue grew 13.0% and free cash flow per share fell 20.2%. Nama's AI scorecard rates it Buy, 6.2 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Buy · 6.2/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Middle · +14.7% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-14.0%

How far the last close sits under the highest price of the past five years.

Market cap	$4.74B
Trailing P/E	17.6
Price / book	3.8
Price / sales	0.8
FCF yield	4.2%
Dividend yield	—
Gross margin	19.1%
Operating margin	5.9%
Net margin	3.7%
Revenue growth (YoY)	+13.0%
Revenue growth (3-yr annual)	+12.7%
EPS growth (YoY)	+34.4%
FCF/share growth (YoY)	-20.2%
Beta	0.6
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Care Facilities

OPCH earnings

Next report: Feb 23, 2027 (Q4 2026, EPS estimate $0.54). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 4, 2026	$0.49	$0.49	+0.0%	$1.49B
Q2 2026	Jul 29, 2026	$0.45	$0.43	+4.7%	$1.44B
Q1 2026	Apr 30, 2026	$0.40	$0.37	+8.1%	$1.35B
Q4 2025	Feb 24, 2026	$0.46	$0.47	-2.1%	$1.47B

OPCH analyst price target

Median target $32.05 from 8 analysts, ranging $23.00 – $33.00.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
HCA	HCA Healthcare	$103.40B	16.5
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
FMS	Fresenius Medical Care	$12.15B	10.2
DVA	DaVita	$12.04B	13.6
UHS	Universal Health Services	$11.52B	8.6
ENSG	Ensign Group	$10.56B	23.8
PACS	PACS Group	$7.87B	20.1

Explore live OPCH data on Nama Insights →

Recent Congressional trades

Option Care Health trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Oct 22, 2025

OPCH FAQ

Is OPCH a buy?: Nama's AI scorecard currently rates Option Care Health Buy (6.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is OPCH's P/E ratio?: Option Care Health trades at a trailing price-to-earnings ratio of 17.6.
When does OPCH report earnings?: Option Care Health's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $0.54.
What is the OPCH price target?: The median analyst price target from 8 analysts is $32.05, with a range of $23.00 – $33.00.
Is OPCH Shariah compliant?: Nama's AAOIFI-style screen reads Option Care Health as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.